Printer Friendly

Antimicrobial drug resistance in Corynebacterium diphtheriae mitis.

To the Editor: Corynebacterium diphtheriae is the agent of pharyngeal and cutaneous diphtheria. We did a retrospective analysis of the antimicrobial drug susceptibilities of 46 C. diphtheriae isolates sent during 1993 through 2010 to the French National Reference Centre of Toxigenic Corynebacteria. The isolates came from metropolitan France and French overseas departments and territories. Only 1 isolate, C. diphtheriae biovar mitis, FRC24, expressed the following anti-microbial drug susceptibility profile: susceptible to penicillin, amoxicillin, ciprofloxacin, clindamycin, erythromycin, gentamicin, imipenem, kanamycin, rifampin, tetracycline, and vancomycin and resistant at an uncommonly high level to trimethoprim, sulfamethoxazole, and co-trimoxazole with Etest (bioMerieux, Marcy l'Etoile, France) MICs of >32, >1,024, and >32 mg/L, respectively.

This FRC24 isolate was isolated in 2008 from a cutaneous wound on a vaccinated 11-month-old child in Mayotte, an overseas department located in the Indian Ocean. Cutaneous carriage of C. diphtheriae is frequent in tropical countries where cutaneous diphtheria is endemic; cutaneous carriage represents a common mode of transmission of the bacterium. FRC24 was identified by using the API Coryne strip (bioMerieux). FRC24 is a toxigenic isolate; toxigenicity was confirmed by both tox gene detection and Elek test (1). Multilocus sequence typing was performed, and the sequence type (ST) of the isolate is ST91. This ST contains only this isolate and is part of lineage II, as are all mitis and gravis biovars (2).

To date, resistance to trimethoprim, sulfamethoxazole, or co-trimoxazole seems to be rare among the C. diphtheriae species, but few data are available (3). As trimethoprim resistance is often encoded by integron-driven dfr determinants, we looked for integrons. Integrons are bacterial genetic elements able to capture and express antimicrobial drug resistance gene cassettes (GCs) (4). GC movements are catalyzed by an integron-encoded integrase IntI. GCs, mainly promoterless, are usually expressed through a common Pc promoter (5). Only rare GCs contain their own promoter (cmlA, qac, ereA1). Three main classes of integrons have been described and are involved in the dissemination of antimicrobial drug resistance; class 1 is the most widely found in clinical isolates. Integrons have been mainly described among gram-negative bacteria; only a few studies have reported integrons in Corynebacterium spp. (6,7).

After bacterial genomic DNA extraction (DNeasy Blood & Tissue Kit; QIAGEN, Courtaboeuf, France), a multiplex Taqman-based quantitative PCR approach able to detect the 3 main classes of integrons was performed (8). We found that FRC24 harbored a class 1 integron. Analysis of the GC array showed that this integron harbored 2 GCs: dfrA16 of 588 bp conferring resistance to trimethoprim and qacH of 511 bp conferring resistance to quaternary ammonium compounds (GenBank accession no. FR822749). To our knowledge, this GC array has not been previously reported, even among reports of other gram-negative isolates. Moreover, a qac determinant has been found only once in a Corynebacterium species, C. pseudogenitalium (which harbors a qacH variant in the chromosome [GenBank accession no. ABYQ02000013]), but not in an integron background. GC arrays were followed by the qacE[DELTA]1 (which also confers resistance to quaternary ammonium compounds), sul1 (resistance to sulfamethoxazole), and orf5 determinants as found in most class 1 integrons (4). In class 1 integrons, 13 Pc variants have been described (5). In the FRC24 integron, the dfrA16 expression was mediated through a strong Pc variant (PcWTGN-10) (5) that enables the high-level resistance observed for trimethoprim. As previously demonstrated, the qacH GC possessed its own promoter (9).

Trimethoprim is a commonly prescribed antimicrobial agent used in combination with sulfamethoxazole (co-trimoxazole) for the treatment of diarrheal diseases. This antimicrobial drug might have selected the emergence of such a strain expressing trimethoprim resistance. Furthermore, the FRC24 integron contains the antiseptic (quaternary ammonium compounds) resistance gene qacH. As cutaneous carriage of C. diphtheriae is frequent in tropical countries such as Mayotte, this bacterium could be exposed to quaternary ammonium compounds contained in disinfectants, hygienic hand washes, and cosmetic products. These products exert a selective pressure, which might play a role in selecting qac-containing strains, as has been suggested for Staphylococcus spp. (10). For staphylococci, the MICs of quaternary ammonium compounds are [greater than or equal to] 2 mg/L. With FRC24, we tested for the MIC of cetyltrimethylammmonium bromide and found a MIC of 4 mg/L, suggesting that qacH is expressed in FRC24.

The sequencing of the genetic environment of this integron showed that it was framed by 2 copies of the insertion sequence IS6100 disrupting at the left-hand side the intI1 integrase gene (online Appendix Figure, EID/article/17/11/11-0282-FA1.htm). IS6100 has been described in a wide spectrum of host organisms, including Corynebacterium spp. (6,7), thus enabling this integron to be efficiently transferred to various bacteria.

Our findings show that C. diphtheriae is able to harbor integrons, which is of clinical relevance. Indeed, this genetic feature would give the isolates the capacity to easily acquire new GCs, such as ere GCs encoding resistance to erythromycin, which is one of the antimicrobial drugs recommended for diphtheria treatment.

This work was supported by grants from Ministere de la Recherche et de l'Enseignement Superieur, Institut National de la Sante et de la Recherche Medicale, and Institut Pasteur Fondation.



(1.) Efstratiou A, Engler KH, Mazurova IK, Glushkevich T, Vuopio-Varkila J, Popovic T. Current approaches to the laboratory diagnosis of diphtheria. J Infect Dis. 2000;181(Suppl 1):S138-45. doi:10.1086/315552

(2.) Bolt F, Cassiday P, Tondella ML, Dezoysa A, Efstratiou A, Sing A, et al. Multilocus sequence typing identifi es evidence for recombination and two distinct lineages of Corynebacterium diphtheriae. J Clin Microbiol. 2010;48:4177-85. doi:10.1128/ JCM.00274-10

(3.) Maple PA, Efstratiou A, Tseneva G, Rikushin Y, Deshevoi S, Jahkola M, et al. The in-vitro susceptibilities of toxigenic strains of Corynebacterium diphtheriae isolated in northwestern Russia and surrounding areas to ten antibiotics. J Antimicrob Chemother. 1994;34:1037-40. doi:10.1093/jac/34.6.1037

(4.) Cambray G, Guerout AM, Mazel D. Integrons. Annu Rev Genet. 2010;44:141-66. doi:10.1146/annurevgenet-102209-163504

(5.) Jov? T, Da Re S, Denis F, Mazel D, Ploy MC. Inverse correlation between promoter strength and excision activity in class 1 integrons. PLoS Genet. 2010;6:e1000793. doi:10.1371/journal.pgen.1000793

(6.) Nesvera J, Hochmannova J, Patek M. An integron of class 1 is present on the plasmid pCG4 from gram-positive bacterium Corynebacterium glutamicum. FEMS Microbiol Lett. 1998;169:391-5. doi:10.1111/j.1574-6968.1998.tb13345.x

(7.) Tauch A, Gotker S, Puhler A, Kalinowski J, Thierbach G. The 27.8-kb R-plasmid pTET3 from Corynebacterium glutamicum encodes the aminoglycoside adenyltransferase gene cassette aadA9 and the regulated tetracycline effl ux system Tet 33 fl anked by active copies of the widespread insertion sequence IS6100. Plasmid. 2002;48:117-29. doi:10.1016/S0147-619 X(02)00120-8

(8.) Barraud O, Baclet MC, Denis F, Ploy MC. Quantitative multiplex real-time PCR for detecting class 1, 2 and 3 integrons. J Antimicrob Chemother. 2010;65:1642-5. doi:10.1093/jac/dkq167

(9.) Naas T, Mikami Y, Imai T, Poirel L, Nordmann P. Characterization of In53, a class 1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes. J Bacteriol. 2001;183:235-49. doi:10.1128/JB.183.1.235-249.2001

(10.) Hegstad K, Langsrud S, Lunestad BT, Scheie AA, Sunde M, Yazdankhah SP. Does the wide use of quaternary ammonium compounds enhance the selection and spread of antimicrobial resistance and thus threaten our health? Microb Drug Resist. 2010;16:91-104. doi:10.1089/mdr.2009.0120

Olivier Barraud, Edgar Badell, Francois Denis, Nicole Guiso, and Marie-Cecile Ploy

Author affiliations: Institut National de la Sante et de la Recherche Medicale, Limoges, France (O. Barraud, F. Denis, M.C. Ploy); University of Limoges, Limoges (O. Barraud, F. Denis, M.-C. Ploy); and Institut Pasteur, Paris, France (E. Badell, N. Guiso)

Address for correspondence: Marie-Cecile Ploy, Institut National de la Sante et de la Recherche Medicale, Equipe Avenir, 2 Rue du Dr Marcland, 87025 Limoges Cedex, France; email:
COPYRIGHT 2011 U.S. National Center for Infectious Diseases
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:LETTERS
Author:Barraud, Olivier; Badell, Edgar; Denis, Francois; Guiso, Nicole; Ploy, Marie-Cecile
Publication:Emerging Infectious Diseases
Article Type:Letter to the editor
Geographic Code:4EUFR
Date:Nov 1, 2011
Previous Article:Disseminated Mycobacterium abscessus infection and showerheads, Taiwan.
Next Article:Transfusion-transmitted syphilis in teaching hospital, Ghana.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters